FDA panel backs Glaxo cervical cancer vaccine | Reuters

Links shared publicly online about this topic.

  • 1,761
    total visits

FDA panel backs Glaxo cervical cancer vaccine | Reuters

reuters.com

GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsement

View full resource at reuters.com

Tags: Vaccination, HPV, Cancer, Cervical Cancer, Women's Health, FDA, Vaccine, GlaxoSmithKline

  • Share

Most Recently Shared on September 9, 2009 at 7:26 pm By:

reutersBenHir Ben Hirschler

Better late than never. Cervarix gets OK from FDA panel but Glaxo's vaccine has missed initial cohort market http://tinyurl.com/mhd4dz

3 years ago...

Also Shared By:

FDA Panel Backs GlaxoSmithKline's Cervical-Cancer Vaccine - WSJ.com

online.wsj.com — “An FDA panel voted in favor of GlaxoSmithKline's Cervarix vaccine, which is designed to protect against cervical cancer.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 2:16 pm By:

focusedonhealth Focused on Health Health Organization

FDA Panel Backs GlaxoSmithKline's Cervical-Cancer Vaccine http://bit.ly/9Z7n2

3 years ago...

FDA Panel Backs Cancer Vaccines - WSJ.com

online.wsj.com — “An FDA panel backed a Glaxo vaccine designed to protect against cervical cancer in women and approved expansion of the use of Merck's competitor vaccine Gardasil in males.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 3:59 am By:

FDA Panel Backs GlaxoSmithKline's Cervical-Cancer Vaccine - WSJ.com

online.wsj.com — “An FDA panel voted in favor of GlaxoSmithKline's Cervarix vaccine, which is designed to protect against cervical cancer.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 1:27 am By:

FDA panel backs Glaxo's cervical vaccine for women

physorg.com — “(AP) -- Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 12:19 am By:

FightCancer FightCancer Health News

FDA panel backs Glaxo's cervical vaccine for women http://bit.ly/1Zasoh

3 years ago...

FDA panel backs Glaxo cervical cancer vaccine | Reuters

reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsementView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2009 at 9:05 pm By:

ONClive Editor Oncology

Big news for Glaxo: ODAC backs approval of Cervarix for females aged 10 to 25. http://tiny.cc/mopeE

3 years ago...

FDA panel backs Glaxo cervical cancer vaccine | Reuters

feeds.reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsementView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2009 at 7:15 pm By:

FDA Panel Backs GlaxoSmithKline's Cervical-Cancer Vaccine - WSJ.com

online.wsj.com — “An FDA panel voted in favor of GlaxoSmithKline's Cervarix vaccine, which is designed to protect against cervical cancer.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on September 9, 2009 at 7:08 pm By:

Advertisement